CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 204 filers reported holding CORCEPT THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $8,834,584 | +38.9% | 271,917 | +7.7% | 0.00% | +100.0% |
Q1 2024 | $6,359,040 | -22.1% | 252,443 | +0.4% | 0.00% | -50.0% |
Q4 2023 | $8,167,518 | +20.8% | 251,463 | +1.3% | 0.00% | 0.0% |
Q3 2023 | $6,761,855 | +18.3% | 248,187 | -3.4% | 0.00% | 0.0% |
Q2 2023 | $5,715,870 | -5.5% | 256,893 | -8.0% | 0.00% | 0.0% |
Q1 2023 | $6,050,958 | +6.3% | 279,361 | -0.3% | 0.00% | 0.0% |
Q4 2022 | $5,691,128 | -19.1% | 280,213 | +2.1% | 0.00% | -33.3% |
Q3 2022 | $7,035,000 | +7.3% | 274,414 | -0.5% | 0.00% | +50.0% |
Q2 2022 | $6,559,000 | +4.7% | 275,802 | -0.8% | 0.00% | 0.0% |
Q1 2022 | $6,264,000 | +13.4% | 278,143 | -0.3% | 0.00% | 0.0% |
Q4 2021 | $5,525,000 | -3.3% | 279,012 | -3.9% | 0.00% | 0.0% |
Q3 2021 | $5,711,000 | -3.5% | 290,211 | +7.8% | 0.00% | 0.0% |
Q2 2021 | $5,921,000 | -27.0% | 269,104 | -21.1% | 0.00% | -33.3% |
Q1 2021 | $8,116,000 | -6.3% | 341,119 | +3.1% | 0.00% | 0.0% |
Q4 2020 | $8,658,000 | +53.5% | 330,983 | +2.1% | 0.00% | 0.0% |
Q3 2020 | $5,641,000 | +5.4% | 324,127 | +1.9% | 0.00% | 0.0% |
Q2 2020 | $5,353,000 | +51.9% | 318,233 | +7.4% | 0.00% | +50.0% |
Q1 2020 | $3,525,000 | -1.4% | 296,437 | +0.3% | 0.00% | 0.0% |
Q4 2019 | $3,575,000 | -8.3% | 295,483 | +7.1% | 0.00% | 0.0% |
Q3 2019 | $3,899,000 | +32.6% | 275,820 | +4.6% | 0.00% | 0.0% |
Q2 2019 | $2,940,000 | -4.9% | 263,673 | +0.1% | 0.00% | 0.0% |
Q1 2019 | $3,093,000 | -3.2% | 263,475 | +9.3% | 0.00% | 0.0% |
Q4 2018 | $3,194,000 | -5.8% | 241,044 | -1.0% | 0.00% | 0.0% |
Q3 2018 | $3,390,000 | +3.3% | 243,395 | +16.8% | 0.00% | -33.3% |
Q2 2018 | $3,281,000 | +3.3% | 208,388 | +6.7% | 0.00% | +50.0% |
Q1 2018 | $3,177,000 | +1.8% | 195,352 | +13.0% | 0.00% | 0.0% |
Q4 2017 | $3,121,000 | +581.4% | 172,821 | +623.4% | 0.00% | – |
Q3 2017 | $458,000 | +65.9% | 23,890 | +2.7% | 0.00% | – |
Q2 2017 | $276,000 | +40.8% | 23,261 | +31.9% | 0.00% | – |
Q1 2017 | $196,000 | +49.6% | 17,638 | -1.5% | 0.00% | – |
Q4 2016 | $131,000 | +107.9% | 17,914 | +80.9% | 0.00% | – |
Q3 2016 | $63,000 | +16.7% | 9,902 | 0.0% | 0.00% | – |
Q2 2016 | $54,000 | – | 9,902 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INGALLS & SNYDER LLC | 8,360,485 | $186,021 | 8.91% |
Novo Holdings A/S | 3,377,768 | $75,155,338 | 5.81% |
Parallel Advisors, LLC | 3,726,565 | $82,916,071 | 2.67% |
TANAKA CAPITAL MANAGEMENT INC | 35,539 | $791 | 2.14% |
S&T BANK/PA | 347,260 | $7,727 | 1.39% |
FAS Wealth Partners, Inc. | 310,771 | $6,914,655 | 0.88% |
Birchview Capital, LP | 50,000 | $1,112,500 | 0.83% |
Granite Investment Partners, LLC | 792,519 | $17,633,548 | 0.70% |
Bridge City Capital, LLC | 60,632 | $1,349,062 | 0.64% |
AJ WEALTH STRATEGIES, LLC | 509,934 | $11,346,032 | 0.55% |